Replies to post #119849 on MedGen Inc (MDIN)

[Scumbag Fraudsters]

In none of MA's recent posts did he say whether he was referring to the Barton era or not.

If he's talkin' 'bout that, then there WAS illegal activity which caused investors to fork over their money. They don't have to be forced for it to be illegal (as I've previously shown).

You may not be talking about Barton anymore, but MA might be. And others still are because they're still holding millions of those phony Barton shares - they didn't just vanish after charges were filed. And as long as those shares remain in our accounts, it's not "history" for us.

It's unclear if the last insane clown posse did anything illegal, but what little they did was murky and suspicious. Lots of grandiose projections made, none executed.

They essentially pumped the stock in their only Letter to Shareholders and 10-Q. As well as creating a website touting the partnerships and inventions about to become part of MDIN. NONE OF WHICH OCCURRED.


They may call these forward-looking statements, but they look like the same ol' fictitious bullshit we got from Barton.

Our vision of becoming The Leader in Technology Commercialization with a Global Portfolio of Industry Improving Lifesciences Companies is now coming into view.

We are building a great company and remain committed to pursuing initiatives that maximize value for all MedGen shareholders.

MedGen, Inc. (OTC:MDIN), is a MedTech and Lifesciences Company Focused on Technology Commercialization and Investment.The company operates in four segments including Biomedical, Healthcare, Precision Medicine,and Pharmaceutical.MedGen’s Portfolio Companies and Divisions offer a range of Products, Solutions,and Services for Sale and Licensing.

First Portfolio Companyemb3Ded Advanced Technologies, Inc. is a spin-off company from North Carolina A&T State University. The Company has secured the exclusive worldwide license of Patent No.: US 8,573,757 B2 (METHOD AND APPARATUS OF MANUFACTURING MICRO AND NANO-SCALE FEATURES).

We plan to add 4 New Co’s in 2018 totaling 12 by 2020. Subsidiaries are expected to include:

1. Medical Device Coating Services (Cardiovascular & Tracheal Stents).
2. Platform Enabling Cell/ Tissue Growth using Bio/ Hydrogels.
3. Direct-Write Printing Devices/ Systems (Configured to Customers’ Requirements).
4. Artificial Human Organs (Extracorporeal) Derived from Biomedical Polyurethanes.

WTH do private placement shares have to do with anything? I think everyone here is only concerned with public offerings.